DaVita Inc.

LSE:0I7E Stock Report

Market Cap: US$12.7b

DaVita Management

Management criteria checks 3/4

DaVita's CEO is Javier Rodriguez, appointed in Jun 2019, has a tenure of 5.5 years. total yearly compensation is $6.71M, comprised of 21% salary and 79% bonuses, including company stock and options. directly owns 1.02% of the company’s shares, worth $129.28M. The average tenure of the management team and the board of directors is 5.2 years and 4.4 years respectively.

Key information

Javier Rodriguez

Chief executive officer

US$6.7m

Total compensation

CEO salary percentage21.0%
CEO tenure5.5yrs
CEO ownership1.0%
Management average tenure5.2yrs
Board average tenure4.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Javier Rodriguez's remuneration changed compared to DaVita's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$828m

Jun 30 2024n/an/a

US$860m

Mar 31 2024n/an/a

US$816m

Dec 31 2023US$7mUS$1m

US$692m

Sep 30 2023n/an/a

US$596m

Jun 30 2023n/an/a

US$454m

Mar 31 2023n/an/a

US$500m

Dec 31 2022US$3mUS$1m

US$547m

Sep 30 2022n/an/a

US$680m

Jun 30 2022n/an/a

US$834m

Mar 31 2022n/an/a

US$903m

Dec 31 2021US$3mUS$1m

US$978m

Sep 30 2021n/an/a

US$984m

Jun 30 2021n/an/a

US$883m

Mar 31 2021n/an/a

US$791m

Dec 31 2020US$73mUS$1m

US$783m

Sep 30 2020n/an/a

US$832m

Jun 30 2020n/an/a

US$824m

Mar 31 2020n/an/a

US$816m

Dec 31 2019US$17mUS$1m

US$705m

Sep 30 2019n/an/a

US$623m

Jun 30 2019n/an/a

US$548m

Mar 31 2019n/an/a

US$551m

Dec 31 2018US$8mUS$900k

US$616m

Sep 30 2018n/an/a

US$617m

Jun 30 2018n/an/a

US$698m

Mar 31 2018n/an/a

US$652m

Dec 31 2017US$8mUS$900k

US$909m

Compensation vs Market: Javier's total compensation ($USD6.71M) is about average for companies of similar size in the UK market ($USD5.77M).

Compensation vs Earnings: Javier's compensation has increased by more than 20% in the past year.

CEO

Javier Rodriguez (53 yo)

5.5yrs

Tenure

US$6,712,328

Compensation

Mr. Javier J. Rodriguez serves as an Independent Director at Gilead Sciences, Inc. since June 15, 2020. He has been Chief Executive Officer and Executive Director of DaVita Inc. since June 1, 2019. Mr. Rod...

Leadership Team

NamePositionTenureCompensationOwnership
Javier Rodriguez
CEO & Executive Director5.5yrsUS$6.71m1.02%
$ 129.3m
Joel Ackerman
CFO & Treasurer7.8yrsUS$6.87m0.11%
$ 14.3m
Kathleen Waters
Chief Legal & Public Affairs Officer8.6yrsUS$5.61m0.073%
$ 9.2m
James Hearty
Chief Compliance Officer6.8yrsUS$2.73m0.015%
$ 1.9m
David Maughan
Chief Operating Officerless than a yearno data0.0073%
$ 928.7k
Christopher Berry
Group VP & Chief Accounting Officer1.3yrsno datano data
Madhu Narasimhan
Chief Information Officerless than a yearno datano data
Nic Eliason
Group Vice President of Investor Relationsno datano datano data
Jessica Hergenreter
Chief People Officerless than a yearno datano data
Misha Palecek
Chief Transformation Officer of U.S. Kidney Care Businessno datano datano data
Jeffrey Giullian
Chief Medical Officer of Kidney Care4.8yrsno datano data
Partha Das
Chief Medical Officer of DaVita International6.3yrsno datano data

5.2yrs

Average Tenure

55yo

Average Age

Experienced Management: 0I7E's management team is seasoned and experienced (5.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Javier Rodriguez
CEO & Executive Director5.5yrsUS$6.71m1.02%
$ 129.3m
Charles Berg
Director17.8yrsUS$322.46k0.032%
$ 4.1m
Barbara Desoer
Independent Director9.2yrsUS$384.96k0.015%
$ 1.8m
Phyllis Yale
Independent Director8.4yrsUS$374.96k0.015%
$ 1.9m
Wendy Schoppert
Independent Director1.4yrsUS$106.86k0.0022%
$ 282.2k
Pamela Arway
Independent Chair15.6yrsUS$497.46k0.030%
$ 3.8m
Dennis Pullin
Independent Directorless than a yearno data0.00075%
$ 94.9k
Adam Schechter
Independent Director2.3yrsUS$334.96k0.0044%
$ 560.5k
Jason Hollar
Independent Director2.6yrsUS$364.96k0.0055%
$ 701.0k
Gregory Moore
Independent Director3.3yrsUS$355.89k0.0070%
$ 888.2k

4.4yrs

Average Tenure

61.5yo

Average Age

Experienced Board: 0I7E's board of directors are considered experienced (4.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 18:12
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DaVita Inc. is covered by 37 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephan GasteygerAtlantic Equities LLP
Brian WilliamsAvondale Partners
Matthew GillmorBaird